Swedish Ibrance Registries Insights (SIRI)
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The main objectives of this study are to describe patient characteristics, treatment patterns and clinical outcomes of patients receiving palbociclib in Swedish clinical practice.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Osoby, które otrzymały co najmniej jedno wypełnione zamówienie na lek palbociclib.
- •Pacjenci, którzy ukończyli 18 lat w określonym dniu badania.
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- March 31, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Pfizer Sweden
Sollentuna, Sweden
Trial contact
Pfizer CT.gov Call Center
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/1/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.